Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11,780.00 GBX | -0.99% | -1.24% | +11.13% |
Sep. 20 | AstraZeneca gets FDA approval for FluMist self-administration | AN |
Sep. 20 | US FDA approves AstraZeneca's self-administered nasal spray flu vaccine | RE |
Composite Fundamentals | Composite Valuation | Composite Consensus | Composite Momentum | Composite Visibility | Investor Rating | ESG Refinitiv | Capi. ($) | ||
---|---|---|---|---|---|---|---|---|---|
B+ | 245B | ||||||||
C+ | 824B | ||||||||
B | 595B | ||||||||
C+ | 397B | ||||||||
C+ | 342B | ||||||||
B- | 297B | ||||||||
A+ | 254B | ||||||||
B- | 235B | ||||||||
C+ | 181B | ||||||||
C+ | 168B | ||||||||
B+ | 145B | ||||||||
B- | 104B | ||||||||
B | 99.38B | ||||||||
B | 85.24B | ||||||||
A- | 78.48B | ||||||||
A- | 65.91B | ||||||||
B+ | 47.33B | ||||||||
B | 47.32B | ||||||||
B | 40.49B | ||||||||
Average | B | 223.74B | |||||||
Weighted average by Cap. | B |
- Stock Market
- Equities
- AZN Stock
- Sector AstraZeneca PLC
- Sector ratings